Skip to search formSkip to main contentSkip to account menu

indium In 111 monoclonal antibody MN-14

Known as: In111 MOAB MN-14, In 111 monoclonal antibody MN-14, In 111 MOAB MN-14 
A radioimmunoconjugate of a murine monoclonal antibody, MoAb MN-14, labeled with indium 111 (In-111). MoAb Lym-1 recognizes an epitope of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
BACKGROUND Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for… 
1999
1999
Nine radioimmunotherapy (RAIT)-naive patients with medullary thyroid cancer received high doses of 131I-MN-14 F(ab)2 anti… 
1997
1997
OBJECTIVES Epithelial ovarian cancer (EOC) is known to produce carcinoembryonic antigen (CEA), and the plasma CEA level is… 
1997
1997
Advanced chemotherapy-resistant ovarian cancer has a poor prognosis, thus requiring new therapeutic modalities. A complete… 
1996
1996
The initial clinical experience with the second‐generation, high‐affinity, MN‐14 immunoglobulin (IgG) anticarcinoembryonic… 
1995
1995
The targeting potential of 131I-labeled NP-4 and MN-14 anti-CEA (carcinoembryonic antigen) monoclonal antibodies (MAbs) was… 
1995
1995
Myelosuppressive toxicity is dose-limiting for radioimmunotherapy. We have reported on the use of cytokine intervention (rhIL-1… 
1990
1990
Tumor targeting of five radioiodinated murine monoclonal antibodies (MAbs) directed against human colorectal cancer were studied…